{"title":"DcMADS3, a MADS-Box Transcription Factor, Highly Expressed at the Middle Flower Bud Stage and Involved in Petalization Development in Carrot.","authors":"Shan-Shan Tan, Shan-Shan Liu, Jing Ma, Yi Liang, Ao-Qi Duan, Yuan-Jie Deng, Ya-Hui Wang, Hui Liu, Zhi-Sheng Xu, Ai-Sheng Xiong","doi":"10.1007/s12033-025-01489-3","DOIUrl":null,"url":null,"abstract":"<p><p>Carrot (Daucus carota), an Apiaceae family crop, possesses the typical compound umbellate inflorescence with small flowers. The mechanism of carrot floral development is still unknown. APETALA3 (AP3) is a MADS-box transcription factor that primarily participates in stamen and petal development. In this study, DcMADS3 belonging to the APETALA3 group was cloned, which can form a heterodimer with DcMADS2 belonging PI (PISTILLATA) group. Expression analysis revealed DcMADS3 was higher in 'Kurodagosun' (normal flower, KRD) than 'Deep Purple' ('petaloid' CMS phenotype, DPP) at the middle flower bud stage. Its expression was greater in DPP petals (normal petal and petaloid petal) than in KRD petals, suggesting its potential role in regulating petalization development in carrot. Transgenic Arabidopsis overexpressing DcMADS3 resulted in altered petal size, increased petal number, and altered flower symmetry. Furthermore, yeast one-hybrid (Y1H) library screening identified DcXTH-like (DCAR_009699) as a potential factor binding to the DcMADS3 promoter. These results provided a theoretical foundation for further investigation of carrot floral organ development mechanism.</p>","PeriodicalId":18865,"journal":{"name":"Molecular Biotechnology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Biotechnology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12033-025-01489-3","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Carrot (Daucus carota), an Apiaceae family crop, possesses the typical compound umbellate inflorescence with small flowers. The mechanism of carrot floral development is still unknown. APETALA3 (AP3) is a MADS-box transcription factor that primarily participates in stamen and petal development. In this study, DcMADS3 belonging to the APETALA3 group was cloned, which can form a heterodimer with DcMADS2 belonging PI (PISTILLATA) group. Expression analysis revealed DcMADS3 was higher in 'Kurodagosun' (normal flower, KRD) than 'Deep Purple' ('petaloid' CMS phenotype, DPP) at the middle flower bud stage. Its expression was greater in DPP petals (normal petal and petaloid petal) than in KRD petals, suggesting its potential role in regulating petalization development in carrot. Transgenic Arabidopsis overexpressing DcMADS3 resulted in altered petal size, increased petal number, and altered flower symmetry. Furthermore, yeast one-hybrid (Y1H) library screening identified DcXTH-like (DCAR_009699) as a potential factor binding to the DcMADS3 promoter. These results provided a theoretical foundation for further investigation of carrot floral organ development mechanism.
期刊介绍:
Molecular Biotechnology publishes original research papers on the application of molecular biology to both basic and applied research in the field of biotechnology. Particular areas of interest include the following: stability and expression of cloned gene products, cell transformation, gene cloning systems and the production of recombinant proteins, protein purification and analysis, transgenic species, developmental biology, mutation analysis, the applications of DNA fingerprinting, RNA interference, and PCR technology, microarray technology, proteomics, mass spectrometry, bioinformatics, plant molecular biology, microbial genetics, gene probes and the diagnosis of disease, pharmaceutical and health care products, therapeutic agents, vaccines, gene targeting, gene therapy, stem cell technology and tissue engineering, antisense technology, protein engineering and enzyme technology, monoclonal antibodies, glycobiology and glycomics, and agricultural biotechnology.